Chester County News and Community Website
PHILADELPHIA, PA — The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for treating uncomplicated urinary tract infections (uUTIs) in adult women and adolescents …
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years Read More
WASHINGTON, D.C. — In a bold leap forward in the fight against antimicrobial resistance (AMR), the U.S. Department of Health and Human Services (HHS), through the Advanced Research Projects Agency for …
HHS Launches TARGET Initiative to Combat Antibiotic Resistance with AI Innovation Read More
MALVERN, PA — Venatorx Pharmaceuticals recently granted exclusive commercial rights to Italy’s Menarini Group for its novel antibiotic, cefepime-taniborbactam. The agreement extends to 96 countries in Europe, Latin America, Middle …
Venatorx Pharmaceuticals Strikes Deal with Menarini Group for Global Rights to Cefepime-Taniborbactam Read More